The overall objective of experiments outlined in this proposal is to study mechanisms of viral latency in the Epstein-Barr virus system and to identify events leading to activation of viral replication. The experiments are predicated on biologic differences which have been discovered in the last granting period between standard EB viruses which remain latent and defective or """"""""het"""""""" strains which do not remain latent and which activate replication. Many experiments focus on the control of expression of an EBV gene, ZEBRA, which activates replication. We will determine, at first by transcriptional analysis how this control differs in the standard and defective viruses. We will attempt to learn how ZEBRA functions by exploration of its viral targets, purification of the ZEBRA polypeptide and studying ZEBRA-DNA and ZEBRA-protein interactions. By analysis of defective variants we hope to learn which viral sequences are responsible for failure of defective viruses to remain latent. We will also attempt to locate replicative origins of DNA synthesis on defective and standard EBVs. The proposed experiments combine biologic, molecular, genetic and biochemical techniques to explore questions bearing on the switch between latency and replication.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Method to Extend Research in Time (MERIT) Award (R37)
Project #
5R37CA012055-22
Application #
3481647
Study Section
Experimental Virology Study Section (EVR)
Project Start
1979-01-01
Project End
1993-12-31
Budget Start
1993-01-01
Budget End
1993-12-31
Support Year
22
Fiscal Year
1993
Total Cost
Indirect Cost
Name
Yale University
Department
Type
Schools of Medicine
DUNS #
082359691
City
New Haven
State
CT
Country
United States
Zip Code
06520
Park, Richard; Miller, George (2018) Epstein-Barr Virus-Induced Nodules on Viral Replication Compartments Contain RNA Processing Proteins and a Viral Long Noncoding RNA. J Virol 92:
Gorres, Kelly L; Daigle, Derek; Mohanram, Sudharshan et al. (2016) Valpromide Inhibits Lytic Cycle Reactivation of Epstein-Barr Virus. MBio 7:e00113
Wang'ondu, Ruth; Teal, Stuart; Park, Richard et al. (2015) DNA Damage Signaling Is Induced in the Absence of Epstein-Barr Virus (EBV) Lytic DNA Replication and in Response to Expression of ZEBRA. PLoS One 10:e0126088
Gorres, Kelly L; Daigle, Derek; Mohanram, Sudharshan et al. (2014) Activation and repression of Epstein-Barr Virus and Kaposi's sarcoma-associated herpesvirus lytic cycles by short- and medium-chain fatty acids. J Virol 88:8028-44
Park, Richard; El-Guindy, Ayman; Heston, Lee et al. (2014) Nuclear translocation and regulation of intranuclear distribution of cytoplasmic poly(A)-binding protein are distinct processes mediated by two Epstein Barr virus proteins. PLoS One 9:e92593
McAllister, Shane C; Shedd, Duane; Mueller, Nancy E et al. (2014) Serum IgA to Epstein-Barr virus early antigen-diffuse identifies Hodgkin's lymphoma. J Med Virol 86:1621-8
El-Guindy, Ayman; Ghiassi-Nejad, Maryam; Golden, Sean et al. (2013) Essential role of Rta in lytic DNA replication of Epstein-Barr virus. J Virol 87:208-23
Yu, Kuan-Ping; Heston, Lee; Park, Richard et al. (2013) Latency of Epstein-Barr virus is disrupted by gain-of-function mutant cellular AP-1 proteins that preferentially bind methylated DNA. Proc Natl Acad Sci U S A 110:8176-81
Daigle, Derek; Gradoville, Lyn; Tuck, David et al. (2011) Valproic acid antagonizes the capacity of other histone deacetylase inhibitors to activate the Epstein-barr virus lytic cycle. J Virol 85:5628-43
Park, Richard; Wang'ondu, Ruth; Heston, Lee et al. (2011) Efficient induction of nuclear aggresomes by specific single missense mutations in the DNA-binding domain of a viral AP-1 homolog. J Biol Chem 286:9748-62

Showing the most recent 10 out of 66 publications